DaVita
DVA
#1634
Rank
C$18.77 B
Marketcap
C$292.50
Share price
-0.37%
Change (1 day)
55.08%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$15.15

According to DaVita's latest financial reports the company's current EPS (TTM) is C$15.40. In 2025 the company made an earnings per share (EPS) of C$14.16 a decrease over its 2024 EPS that were of C$15.44.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$15.156.96%
2025C$14.16-8.25%
2024C$15.4444.94%
2023C$10.6527.26%
2022C$8.37-35.56%
2021C$12.9944.1%
2020C$9.0119.7%
2019C$7.53540.48%
2018C$1.18-76.07%
2017C$4.91-19.31%
2016C$6.09242.52%
2015C$1.78-62.87%
2014C$4.7913.43%
2013C$4.228.45%
2012C$3.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$34.03 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$15.90 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$27.22 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.70-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA